It was also discovered that a short peptide expressed by CAR T cells could disrupt the protein kinase A (PKA, PGE2 downstream target protein) signals, which in turn increases CXCR-3 expression leading to an increase in CAR T cell infiltration into active tumor regions and enhanced tumor cell killing potential [342]. This evidence concerns the gene CXCR3 and neoplasm.